Press Room

Axichem is an innovative biotechnology company specialising in development of natural analogue, safe components.

Read more
All Press Releases
Financial Reports
News
SubscribePress Contact
Regulatory Press Releases
March 10, 2026
aXichem genomför en riktad emission av units till garant i samband med den genomförda företrädesemissionen
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
March 10, 2026
aXichem carries out a directed issue of units to guarantor in connection with the completed rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
March 02, 2026
aXichem announces final outcome of the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
March 02, 2026
aXichem offentliggör slutligt utfall i företrädesemissionen
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
February 27, 2026
aXichem announces preliminary outcome of the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
February 27, 2026
aXichem offentliggör preliminärt utfall i företrädesemissionen
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
February 19, 2026
aXichem AB (publ), Bokslutskommuniké, januari – december 2025
aXichems utveckling under perioden 2025-01-01—2025-12-31 I denna delårsrapport presenteras koncernen Read the article here
February 19, 2026
aXichem AB (publ), Year End Report, January – December 2025
aXichem’s development during the period 2025-01-01—2025-12-31 In this interim report, Read the article here
February 03, 2026
aXichem genomför företrädesemission av units om cirka 11 MSEK
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
February 03, 2026
aXichem carries out a rights issue of units of approximately SEK 11 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
SubscribePress Contact